The Axtria Collective | August 2024 Edition
Axtria - Ingenious Insights
Better health outcomes with AI, Digital Transformation, and Omnichannel.
Welcome to the Axtria Collective!
This edition features a case study on Axtria's partnership with a leading biopharma company that resulted in a $25 million revenue lift. You'll also find a report on leveraging GenAI's conversational capabilities for exploratory data analysis, along with articles on the three Es of GenAI and how GenAI can streamline the authoring of Clinical Study Reports (CSRs).
Happy reading!
??Axtria Ignite Webinars
Improve Sales Rep Efficiency and HCP Engagement with AI-powered Field Force Operations
Can AI give you a competitive advantage in a rapidly evolving market? While AI is becoming integral to commercial strategy, its effectiveness compared to traditional methods is still debated. Join us on Tuesday, September 24, at 1:00 PM ET, and learn how to identify winning AI use cases, address adoption barriers, and measure ROI from AI-driven approaches.
Going Beyond Pilots: Implementing GenAI for True Value Generation
While many life sciences organizations are experimenting with GenAI, scaling and deploying these solutions remain challenging. Join us on Tuesday, October 29, at 1:00 PM ET to learn about the seven pillars of GenAI success, a framework for driving enterprise-level value, and discuss insights on the future of GenAI-based value creation derived from over 30 industry leaders.
?Featured Content
Driving $25 Million Impact with a Data Science and Analytics Center of Excellence
A leading biopharma company partnered with Axtria to establish a Data Science and Analytics Center of Excellence (CoE) – a collaboration that resulted in a $25 million revenue lift. The CoE enhanced efficiency, drove innovation, and ensured regulatory compliance, transforming the company’s approach to commercial analytics. Read this case study to learn about the AI/ML models, intelligent bots, and other innovative solutions that powered this success.
??Report
Exploratory Data Analysis With Generative AI
Life sciences organizations depend on timely, data-driven insights for effective decision-making. However, the complexity and volume of data available often hinder the extraction of valuable insights. This report explores how GenAI can transform data exploration and offers a step-by-step guide to leverage advanced AI techniques for patient analytics.
领英推荐
?? Leaders’ Perspective
The Three Es of GenAI
The world is advancing rapidly with GenAI. While some enterprises are just starting, others are already applying it in real-world scenarios. Navdeep Chadha, Co-founder and CTO of Axtria, explains how successful companies use the three Es of GenAI - experiences, efficiencies, and effectiveness - to drive innovation and productivity.
??Timeless Insights
Rescuing Clinical Study Reports: 30% Faster Authoring With Generative AI
Documentation of clinical trial outcomes is essential for the approval and launch of new pharmaceutical products. However, the traditional process of creating Clinical Study Reports (CSRs) is labor-intensive. This article explores how GenAI can streamline CSR authoring, enhancing speed, accuracy, and quality.
??Upcoming Event
DATADRIVEN2024
We are thrilled to announce Axtria’s participation as a Gold Sponsor at the upcoming DATADRIVEN2024 conference, which will be held from October 7–9, 2024 in Orlando, FL. Stop by our booth to hear how Axtria can help you unlock solutions for your data management and analytics challenges.
??News Capsule
Axtria Named a Leader in 2024 Data Science Service Providers PeMa Quadrant by Analytics India Magazine
Axtria has been recognized as a Leader and ranked among the Top 5 in the 2024 Data Science Service Providers Penetration and Maturity (PeMa) Quadrant by Analytics India Magazine. As the industry embraces GenAI and cloud-native solutions, Axtria is at the forefront, driving innovation and improved patient outcomes.
We’re Doubling Our Headquarters in NJ!
We are thrilled to expand our headquarters in Berkeley Heights, NJ, to accommodate our growth and future plans. This is a testament to our ongoing momentum, the contributions of our exceptional employees, and the value our leading products provide our valued clients.